Influence of neurotransmitter receptor variants on interactions with psychotropic drugs

Influence of neurotransmitter receptor variants on interactions with psychotropic drugs

Show other versions (2)
Saved in:
Bibliographic Details
Other Authors: Arranz, Maria J. (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2014.
Series:Henry Stewart talks. Biomedical & life sciences collection. Psychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs.
Subjects:
Dopaminergic mechanisms.
Mental illness > Chemotherapy.
Mental illness > Genetic aspects.
Neurotransmitter receptors.
Pharmacogenetics.
Psychopharmacology.
Dopamine > pharmacology.
Dopamine > physiology.
Mental Disorders > drug therapy.
Mental Disorders > genetics.
Psychotropic Drugs.
Receptors, Dopamine > genetics.
Receptors, Neurotransmitter > genetics.
Receptors, Serotonin > genetics.
Serotonin > pharmacology.
Serotonin > physiology.
Treatment Outcome.
Online Access:https://hstalks.com/bs/266/
Series
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000cgm a2200000 a 4500
001 HST1148_1_2
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 160129s2014 enk|||||||||||s|||v|eng d
028 5 0 |a 1148  |b Henry Stewart Talks 
035 |a (UkLoHST)266 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Arranz, Maria J.  |4 spk 
245 1 0 |a Influence of neurotransmitter receptor variants on interactions with psychotropic drugs  |h [electronic resource] /  |c Maria J. Arranz. 
260 |a London :  |b Henry Stewart Talks,  |c 2014. 
300 |a 1 online resource (1 streaming video file (25 min.) :  |b color, sound). 
490 1 |a Psychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs,  |x 2056-452X 
500 |a Animated audio-visual presentation with synchronized narration. 
500 |a Revised version of a talk first published in 2007. 
500 |a Title from title frames. 
505 0 |a Contents: Pharmacological treatment in psychiatry -- Causes of treatment variability -- Genetic influence on drug-target interactions -- Pharmacological profile of psychotropics -- The dopaminergic system and drug response -- Genetic influence on dopaminergic interactions -- The dopaminergic system and drug response -- Genetic influence on serotonergic interactions -- Genetic variants and associations with treatment efficacy and side effects. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Dopaminergic mechanisms. 
650 0 |a Mental illness  |x Chemotherapy. 
650 0 |a Mental illness  |x Genetic aspects. 
650 0 |a Neurotransmitter receptors. 
650 0 |a Pharmacogenetics. 
650 0 |a Psychopharmacology. 
650 2 |a Dopamine  |x pharmacology. 
650 2 |a Dopamine  |x physiology. 
650 2 |a Mental Disorders  |x drug therapy. 
650 2 |a Mental Disorders  |x genetics. 
650 2 |a Pharmacogenetics. 
650 2 |a Psychopharmacology. 
650 2 |a Psychotropic Drugs. 
650 2 |a Receptors, Dopamine  |x genetics. 
650 2 |a Receptors, Neurotransmitter  |x genetics. 
650 2 |a Receptors, Serotonin  |x genetics. 
650 2 |a Serotonin  |x pharmacology. 
650 2 |a Serotonin  |x physiology. 
650 2 |a Treatment Outcome. 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Psychopharmacogenetics : genetic factors influencing the kinetics and dynamics of psychotropic drugs. 
856 4 0 |u https://hstalks.com/bs/266/ 
856 4 2 |u https://hstalks.com/bs/p/35/  |3 Series 
999 |c 200952  |d 200952 

Similar Items